Toggle Side Panel
News + Resources
Market Trends
Downloads & Resources
CDMO News
CRO News
Biotech Profiles
Podcast
Directory
Events
CDMO Live Europe
CDMO Live Americas
ExM Leaders
More options
Sign in
Sign up
Search for:
News + Resources
Market Trends
Downloads & Resources
CDMO News
CRO News
Biotech Profiles
Podcast
Directory
Events
CDMO Live Europe
CDMO Live Americas
ExM Leaders
Search for:
Close search
Policy Briefings
Section 232 Pharma Tariffs Expand Today: What Manufacturers Need to Know
MFN Deal Includes Revenue-Sharing With HHS on Overseas Sales
China Aims for 25% of Global First-in-Class Drugs by 2030
AstraZeneca Signs Trump’s Second MFN Drug Pricing Deal
Trump Exempts Generic Drugs from Pharmaceutical Tariffs, Boosting Indian Pharma Stocks
UK Considers Raising NHS Drug Prices to Avoid US Tariffs
Trump Delays 100% Pharma Tariffs to Negotiate Pricing Deals
TrumpRx: Pfizer Signs First Deal for US Drug Platform
Trump’s 100% Pharma Tariffs to United States from October 1: How the industry is responding
Trump Administration Draws Autism-Acetaminophen Link Despite Scientific Skepticism
RFK Jr’s Vaccine Panel Expected to Delay Newborn Hepatitis B Shots Until Age 4
US-EU Trade Deal Caps Pharmaceutical Tariffs at 15%, Averting Higher Levies
« Previous
Page
1
Page
2
Next »
Genezen Partners With InterAct Therapeutics on AAV8 Cancer Gene Therapy
Curia Invests $28 Million in Sterile API Manufacturing
MedPharm Signs Commercial Manufacturing Agreement With Global Pharmaceutical Company
Catalent Launches 10-Month Gene-to-Drug Substance Program for Complex Biologics
GE HealthCare to Acquire SOFIE Biosciences for $945 Million
Flamma Acquires Lundbeck API Site in Italy
Sterling Pharma Solutions Expands UK Bioconjugation Capacity With Multi-Million-Pound Investment
Hovione Invests $35M in Next-Generation Continuous Tableting Line
Piramal Pharma Solutions and NP2 Advance Generic Cancer Drug Development
Biological E. Appoints V Krishnakumar as CEO of Biopharma CDMO
Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing
SK pharmteco Announces $200M+ U.S. Investment in Small Molecules and Peptides
53Biologics Announces €2M+ Investment in New Lyophilization Capacity
TAPI Appoints Serge Rogasik as Chief Executive Officer
ALK Expands Catalent Partnership to Secure Long-Term Allergy Tablet Supply
OnDosis and Adare Pharma Solutions Launch U.S. ADHD Drug-Device Collaboration
Ensera Launches Alliance Network for Drug-Device Combination Products
Merck Opens €70M Expansion at St. Louis ADC Manufacturing Center
« Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next »
European CDMO Landscape 2025:
Download the latest edition